The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of S-1 plus docetaxel as first-line treatment for elderly patients with advanced gastric cancer (OGSG0902).
 
Jin Matsuyama
No Relationships to Disclose
 
Hiroshi Imamura
No Relationships to Disclose
 
Ryohei Kawabata
No Relationships to Disclose
 
Tomono Kawase
No Relationships to Disclose
 
Kazuyuki Okada
No Relationships to Disclose
 
Kazuhiro Nishikawa
Honoraria - Ajinomoto; Chugai Pharma; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Taiho Pharmaceutical
 
Yukinori Kurokawa
Honoraria - Chugai Pharma; Lilly Japan; Novartis; Pfizer; Taiho Pharmaceutical; Yakult Honsha
 
Kazumasa Fujitani
No Relationships to Disclose
 
Toshio Shimokawa
No Relationships to Disclose
 
Taroh Satoh
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck Serono; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin; Lilly; Merck Serono; Ono Pharmaceutical; Takara Bio
Research Funding - Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Yakult Honsha (Inst)